Conjugated additions of amines and β-amino alcohols to trifluorocrotonic acid derivatives: synthesis of ψ[NHCH(CF3)]-retro-thiorphan

Tetrahedron Letters

Volumn 48, Issue 4, 2007, Pages 589-593

  Molteni, Marco ^a   Volonterio, Alessandro ^a   Fossati, Giacomo ^a   Lazzari, Paolo ^b   Zanda, Matteo ^c  

^a POLITECNICO DI MILANO   (Italy)

^b Neuroscienze PharmaNess Scarl   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOALCOHOL; CROTONIC ACID DERIVATIVE; ETHYLAMINE; N TRIFLUOROCROTONOYLOXAZOLIDIN 2 ONE; OXAZOLIDINE DERIVATIVE; RETROTHIORPHAN; TRIFLUOROCROTONIC ACID DERIVATIVE; TRIFLUOROETHYLAMINE; UNCLASSIFIED DRUG;

ARTICLE; DIASTEREOISOMER; DRUG STRUCTURE; DRUG SYNTHESIS; LOW TEMPERATURE; MICHAEL ADDITION; REACTION ANALYSIS; STEREOCHEMISTRY; STRUCTURE ANALYSIS; TEMPERATURE DEPENDENCE;

EID: 33845743839     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2006.11.124     Document Type: Article

References (24)

1. Zanda M. New J. Chem. 28 (2004) 1401-1411
2. Begué J.-P., Bonnet-Delpon D., Crousse B., and Legros J. Chem. Soc. Rev. 34 (2005) 562-572
3. Gong Y.F., and Kato K. Curr. Org. Chem. 8 (2005) 1659-1675
4. Sani M., Molteni M., Bruché L., Volonterio A., and Zanda M. In: Soloshonok V.A. (Ed). Fluorine-Containing Synthons (2005), ACS Publications Division and Oxford University Press, Washington, DC 572-592
5. Volonterio A., Bravo P., and Zanda M. Org. Lett. 2 (2000) 1827-1830
6. Volonterio A., Bellosta S., Bravin F., Bellucci M.C., Bruché L., Colombo G., Malpezzi L., Mazzini S., Meille S.V., Meli M., Ramirez de Arellano C., and Zanda M. Chem. Eur. J. 9 (2003) 4510-4522
7. Molteni M., Volonterio A., and Zanda M. Org. Lett. 5 (2003) 3887-3890
8. Black W.C., Bayly C.I., Davis D.E., Desmarais S., Falgueyret J.-P., Léger S., Li C.S., Massé F., McKay D.J., Palmer J.T., Percival M.D., Robichaud J., Tsou N., and Zamboni R. Bioorg. Med. Chem. Lett. 15 (2005) 4741-4744
9. Li C.S., Deschenes D., Desmarais S., Falgueyret J.-P., Gauthier J.Y., Kimmel D.B., Léger S., Massé F., McGrath M.E., McKay D.J., Percival M.D., Riendeau D., Rodan S.B., Thérien M., Truong V.-L., Wesolowski G., Zamboni R., and Black W.C. Bioorg. Med. Chem. Lett. 16 (2006) 1985-1989
10. Link J.O., and Zipfel S. Curr. Opin. Drug Discovery Dev. 9 (2006) 471-482
11. Fletcher M.D., and Campbell M.M. Chem. Rev. 98 (1998) 763-795
12. Goodman M., and Chorev M. Acc. Chem. Res. 12 (1979) 1-7
13. Roques B.P., Lucas-Soroca E., Chaillet P., Costentin J., and Fournié-Zaluski M.C. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 3178-3182
14. 3): δ 7.29 (m, 5H), 4.39 (m, 1H), 4.21 (m, 2H), 4.03 (d, J = 13.2 Hz, 1H), 3.85 (d, J = 13.2 Hz, 1H), 3.79 (m, 1H), 3.43 (dd, J = 16.2 and 9.4 Hz, 1H), 3.11 (dd, J = 16.2 and 4.1 Hz, 1H), 2.39 (m, 1H), 0.92 (d, J = 7.1 Hz, 3H), 0.84 (d, J = 6.8 Hz, 3H).
15. Another possible pathway to 6 could be the fragmentation into ketene 7 and the corresponding deacylated 2-oxazolidinone, followed by reaction with benzylamine.{A figure is presented} The protic acids successfully used in Table 1, entries 1-5,11 could therefore play the role of rapidly quenching the intermediate α-carbonyl carbanion formed by aza-Michael addition, thus suppressing the fragmentation via ketene 7. The formation of ketenes by fragmentation of N-acyl-oxazolidinones has been observed previously: Bravo, P.; Fustero, S.; Guidetti, M.; Volonterio, A.; Zanda, M. J. Org. Chem. 1999, 64, 8731-8735 and references cited therein. Attempts to isolate these hypothetic ketene intermediates by adding external nucleophiles, such as dialkylamines, in the reaction mixture were unsuccessful.
16. 3a,3b.
17. 3): δ 7.33-7.18 (m, 5H), 4.41 (m, 1H), 4.23 (m, 2H), 3.86 (m, 1H), 3.49-3.32 (m, 4H), 3.04 (dd, J = 16.6 and 3.9 Hz, 1H), 2.85 (dd, J = 13.5 and 7.3 Hz, 1H), 2.74 (dd, J = 13.5 and 6.2 Hz, 1H), 2.40 (m, 1H), 1.61 (br s, 1H), 0.91 (d, J = 6.9 Hz, 3H), 0.86 (d, J = 6.9 Hz, 3H).
18. D -23.3 (c 0.6, methanol).
19. Compounds 1 are indefinitely stable upon storage at 4 °C (neat). However, the stability is much lower when diastereomers 1 are stored in solution at room temperature, and definitely low when heated in the presence of bases, and in general at pH > 7. This precluded, in our hands, the possibility to isolate diastereopure 1 by crystallization with chiral bases.
20. Florentin D., Sassi A., and Roques B.P. Anal. Biochem. 141 (1984) 62-69
21. Roques B.P., Noble F., Daugé V., Founie-Zaluski M.C., and Beaumont A. Pharmacol. Rev. 45 (1993) 87-146
22. Gomez-Monterrey I., Beaumont A., Nemecek P., Roques B.P., and Fournie-Zaluski M.-C. J. Med. Chem. 37 (1994) 1865-1873
23. Coric P., Turcaud S., Meudal H., Roques B.P., and Fournie-Zaluski M.C. J. Med. Chem. 39 (1996) 1210-1219 and references cited therein
24. Dunitz J.D., and Taylor R. Chem. Eur. J. 3 (1997) 89-98